Hemolytic disease of the newborn (patient information): Difference between revisions
No edit summary |
m Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu) |
||
(One intermediate revision by one other user not shown) | |||
Line 3: | Line 3: | ||
{{Hemolytic disease of the newborn (patient information)}} | {{Hemolytic disease of the newborn (patient information)}} | ||
'''Editor-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto: | '''Editor-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor-In-Chief:''' [[Lakshmi Gopalakrishnan]], M.B.B.S. | ||
==Overview== | ==Overview== | ||
Line 58: | Line 58: | ||
==Source== | ==Source== | ||
http://www.nlm.nih.gov/medlineplus/ency/article/001298.htm | http://www.nlm.nih.gov/medlineplus/ency/article/001298.htm | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
[[Category:Template complete]] | [[Category:Template complete]] | ||
[[Category:Disease]] | |||
[[Category:Disease | |||
[[Category:Patient information]] | [[Category:Patient information]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Hematology patient information]] | [[Category:Hematology patient information]] | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
[[Category:Obstetrics patient information]] | [[Category:Obstetrics patient information]] | ||
[[Category:Neonatology]] | [[Category:Neonatology]] | ||
[[Category:Neonatology patient information]] | [[Category:Neonatology patient information]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Pediatrics patient information]] | [[Category:Pediatrics patient information]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Transfusion medicine]] | [[Category:Transfusion medicine]] | ||
Latest revision as of 16:45, 1 November 2012
For the WikiDoc page for this topic, click here
Hemolytic disease of the newborn |
Where to find medical care for Hemolytic disease of the newborn? |
---|
Hemolytic disease of the newborn On the Web |
Directions to Hospitals Treating Hemolytic disease of the newborn |
Risk calculators and risk factors for Hemolytic disease of the newborn |
Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Associate Editor-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.
Overview
Erythroblastosis fetalis is a potentially life-threatening blood disorder in a fetus or newborn infant. This article provides a general overview.
What are the symptoms of Hemolytic disease of the newborn?
Symptoms in a newborn baby may include:
- Anemia
- Edema (swelling under the surface of the skin)
- Enlarged liver or spleen
- Hydrops (fluid throughout the body's tissues, including in the spaces containing the lungs, heart, and abdominal organs)
- Newborn jaundice
What causes Hemolytic disease of the newborn?
- Erythroblastosis fetalis develops in an unborn infant when the mother and baby have different blood types. The mother produces substances called antibodies that attack the developing baby's red blood cells.
- The most common form of erythroblastosis fetalis is ABO incompatibility, which can vary in severity.
- The less common form is called Rh incompatibility, which can cause very severe anemia in the baby.
Diagnosis
Specific tests depend on the type of erythroblastosis, but may include:
- Complete blood count
- Bilirubin level
- Blood typing
Treatment options
- After birth, depending on the severity, a transfusion usually needs to be performed.
- For specific treatment information, see:
Where to find medical care for Hemolytic disease of the newborn?
Directions to Hospitals Treating Hemolytic disease of the newborn
What to expect (Outlook/Prognosis)?
The severity of this condition can vary widely.
- In some instances, the baby has no symptoms of the disease.
- In other cases, it can lead to death of the baby before or shortly after birth.
- It can be treated before birth by intrauterine transfusion.
Possible complications
Complications depend on the specific type of erythroblastosis fetalis.
Prevention
- The most severe form of this disease, Rh incompatibility, can be prevented if the mother takes a medicine called RhoGAM at certain times during and after pregnancy.
- If you have had a baby with this disease, be sure to talk with your doctor if you plan on having another baby.
Source
http://www.nlm.nih.gov/medlineplus/ency/article/001298.htm Template:WH Template:WS